What health screenings are recommended for a 61‑year‑old man?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Health Screening Recommendations for a 61-Year-Old Man

A 61-year-old man should undergo colorectal cancer screening (colonoscopy every 10 years or annual FIT), discuss prostate cancer screening with PSA testing based on informed decision-making, and receive one-time abdominal aortic aneurysm ultrasound screening if he has ever smoked.

Colorectal Cancer Screening

Begin or continue colorectal cancer screening immediately if not already up to date. At age 61, this man is in the prime screening window (ages 45-75 years) where screening provides maximum benefit 1. The evidence shows that screening from ages 45-75 prevents 42-61 colorectal cancer cases and averts 24-28 deaths per 1000 adults screened 1.

Screening options include:

  • Colonoscopy every 10 years (most comprehensive, detects and removes polyps)
  • Annual fecal immunochemical testing (FIT) (non-invasive, done at home)
  • CT colonography every 5 years
  • Flexible sigmoidoscopy every 5 years (can combine with annual FIT)

Colonoscopy or FIT are the most practical first-line choices 2, 1. Colonoscopy offers the advantage of simultaneous polyp removal, while FIT provides a non-invasive annual option with comparable mortality reduction when performed correctly.

Prostate Cancer Screening

Engage in shared decision-making about PSA screening. At age 61, this man falls within the 55-69 year age range where PSA screening may provide benefit, but the decision must be individualized 3.

Key discussion points before testing:

  • PSA screening may reduce prostate cancer mortality by a small margin, but evidence remains controversial 3
  • Screening leads to overdiagnosis and overtreatment in many men whose cancer would never have caused symptoms
  • Treatment complications include urinary incontinence, erectile dysfunction, and bowel problems 4
  • False-positive results lead to unnecessary biopsies with associated risks 5

If the patient chooses screening after informed discussion:

  • Perform PSA test annually if PSA ≥2.5 ng/mL
  • Screen every 2 years if PSA <2.5 ng/mL 4
  • Consider adding digital rectal examination, though PSA is more sensitive 6

The 2018 USPSTF guidelines emphasize that for men aged 55-69, the decision should involve providing information about potential benefits and harms, then allowing individual choice 3. Do not screen if life expectancy is less than 10 years due to comorbidities 4.

Abdominal Aortic Aneurysm (AAA) Screening

Perform one-time ultrasound screening if the patient has ever smoked (even a single cigarette qualifies as "ever smoked") 7. This is a Grade B recommendation with strong evidence showing that screening reduces AAA rupture deaths by approximately 50% in men aged 65-75 who have ever smoked 7.

If the patient has never smoked: Screening may be selectively offered based on individual risk factors (family history, other cardiovascular risk factors), but routine screening is not recommended 7. The benefit is small in never-smokers, though not zero.

The screening is simple, safe, painless, and done only once—not repeated 7.

Additional Screening Considerations

Cardiovascular risk assessment:

  • Blood pressure measurement at every visit
  • Lipid screening (already indicated at age 61 for cardiovascular risk assessment) 8
  • Calculate body mass index and assess for obesity 8

Lung cancer screening:

  • If 20+ pack-year smoking history and currently smokes or quit within past 15 years: Annual low-dose CT screening is recommended (ages 50-80) 9
  • This requires willingness to undergo curative surgery if cancer is detected 9

Immunizations:

  • Update per Advisory Committee on Immunization Practices guidelines (influenza, pneumococcal, Tdap, zoster, COVID-19) 8

Common Pitfalls to Avoid

  • Do not perform PSA screening without the informed decision-making discussion—this violates guideline recommendations and ethical standards 5, 4
  • Do not skip AAA screening in former smokers—even remote smoking history qualifies for screening 7
  • Do not continue colorectal cancer screening beyond age 85 or when life expectancy is less than 10 years 5
  • Do not use in-office single-panel FOBT from digital rectal exam—it has inadequate sensitivity 2

Related Questions

What is the most common heart murmur encountered in clinical practice?
How do I convert an infusion rate of 60 cc per hour to drops per minute using a microdrip set?
For a 36‑year‑old woman with right breast pain, should I order a diagnostic computer‑aided mammogram and targeted ultrasound of the right breast only, and is imaging of the asymptomatic left breast required at this age?
How should a 50-year-old man with left shoulder pain be evaluated and managed?
In a 55‑year‑old man with a recent electrocardiogram showing sinus rhythm, a QS complex in V1, poor R‑wave progression in V2, left‑atrial enlargement, and a prolonged QT interval, what is the most likely diagnosis and appropriate treatment?
How should bradycardia be managed in a geriatric patient with Alzheimer’s disease who is taking donepezil?
What is the recommended protocol for administering and assessing Radiesse (calcium hydroxylapatite) in adult patients with moderate to severe facial volume loss?
In an 84-year-old man with benign prostatic hyperplasia taking finasteride 5 mg daily and tamsulosin (Flomax) 0.4 mg daily who has recurrent urinary symptoms, should the tamsulosin dose be increased to two tablets (0.8 mg) daily?
Is enalapril safe during lactation?
Can Sjögren's syndrome cause facial swelling due to salivary gland enlargement?
Should a patient with epigastric pain and ultrasound findings of hepatomegaly (19.4 cm) and hepatic steatosis, with otherwise normal abdominal imaging, be referred to gastroenterology/hepatology for further evaluation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.